Status:
COMPLETED
A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
Lead Sponsor:
Organon and Co
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
40+ years
Phase:
PHASE3
Brief Summary
The purpose of this study and 12 month extension is to evaluate the effects of two investigational drugs on osteoporosis in postmenopausal women.
Eligibility Criteria
Inclusion
- Postmenopausal women with osteoporosis
Exclusion
- Any known allergy to the study drug
Key Trial Info
Start Date :
March 18 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2005
Estimated Enrollment :
936 Patients enrolled
Trial Details
Trial ID
NCT00092040
Start Date
March 18 2003
End Date
September 28 2005
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.